sch 34826 has been researched along with Blood Pressure, High in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cigola, E; Monopoli, A; Olivetti, G; Ongini, E | 1 |
| Crozier, IG; Espiner, EA; Frampton, C; Ikram, H; Kosoglou, T; Rallings, M; Richards, AM; Yandle, TG | 1 |
| Chen, YF; Esunge, P; Jin, H; Mathews, C; Oparil, S; Wyss, JM; Yang, R | 1 |
| Brown, A; Chiu, PJ; Griscti, K; Sybertz, EJ; Vemulapalli, S | 1 |
| Sybertz, EJ | 1 |
| Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW | 2 |
| Forlani, A; Monopoli, A; Ongini, E | 1 |
| Chiu, PJ; Haslanger, MF; Sybertz, EJ; Vemulapalli, S; Watkins, R | 1 |
1 review(s) available for sch 34826 and Blood Pressure, High
| Article | Year |
|---|---|
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dioxolanes; Dipeptides; Drug Synergism; Heart Failure; Humans; Hypertension; Neprilysin; Prodrugs; Rats | 1991 |
1 trial(s) available for sch 34826 and Blood Pressure, High
| Article | Year |
|---|---|
Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Topics: Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dipeptides; Double-Blind Method; Epinephrine; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Neprilysin; Norepinephrine; Renin-Angiotensin System | 1992 |
7 other study(ies) available for sch 34826 and Blood Pressure, High
| Article | Year |
|---|---|
The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Dioxolanes; Dipeptides; Hemodynamics; Hypertension; Male; Microscopy, Electron; Myocardium; Neprilysin; Rats; Rats, Inbred SHR; Ventricular Function, Left | 1992 |
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats.
Topics: Administration, Oral; Analgesics; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dipeptides; Hypertension; Male; Protease Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Sodium Chloride | 1992 |
The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Kidney; Male; Neprilysin; Peptide Fragments; Rats | 1991 |
Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Drug Synergism; Hypertension; Iodine Radioisotopes; Kinins; Male; Metalloendopeptidases; Rats; Rats, Inbred Strains; Thiorphan | 1991 |
Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Dioxolanes; Dipeptides; Enalapril; Hypertension; Methionine; Myocardium; Neprilysin; Rats; Rats, Inbred SHR | 1991 |
Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Male; Methionine; Neprilysin; Rats; Rats, Inbred Strains; Sodium, Dietary | 1990 |
Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dioxoles; Dipeptides; Drug Synergism; Hemodynamics; Hypertension; Kidney; Male; Neprilysin; Rats; Rats, Inbred SHR | 1990 |